Form 4: ICAD INC Director Hedvig Hricak Acquires Stock Options in Lieu of Cash Fees

Director Hedvig Hricak acquired 5,415 stock options in ICAD INC on April 1, 2024, in lieu of quarterly cash director fees.

Summary

• Hedvig Hricak, a director of ICAD INC, acquired 5,415 stock options on April 1, 2024.
• The options were granted in lieu of quarterly cash director fees.
• The exercise price of the options is $1.52.
• The options are immediately exercisable and expire on April 1, 2034.
• The underlying security is common stock, with 5,415 shares.
• Following the transaction, Hricak directly owns 5,415 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction. The director taking stock options instead of cash could be seen as a slightly positive sign.

Positives

• A director taking stock options in lieu of cash fees can be seen as a positive sign, aligning their interests with shareholders.

Industry Context

This is a standard practice for compensating board members, particularly in smaller companies or those looking to conserve cash.

Comparison to Industry Standards

• Director compensation packages vary widely across industries and company sizes.
• Stock options are a common component of director compensation, especially in growth-oriented companies.
• Comparing ICAD INC's director compensation to similar-sized companies in the medical technology sector would provide a better benchmark.

Stakeholder Impact

• Shareholders may view this as a positive sign, aligning director interests with company performance.
• The company conserves cash by issuing stock options instead of paying cash fees.

Key Dates